Wake Research
Wake Research is an integrated U.S. clinical research site network operating 18+ wholly owned investigational clinics across seven states, conducting multi-specialty trials for biopharma, biotech, medical device sponsors, and CROs under parent M3, Inc.
- Company typePrivate
- Founded2004
- HeadquartersRaleigh, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Wake Research does
Wake Research (legally M3 Wake Research) is an integrated, wholly owned clinical research site organization headquartered in Raleigh, North Carolina, and a wholly owned subsidiary of M3, Inc. (TYO: 2413), a publicly traded Japanese clinical research and healthcare technology company. Founded in 1984, the company operates 18+ premier investigational sites across seven U.S. states staffed by 65+ principal investigators and sub-investigators, with access to over 1 million patients through affiliations with multi-specialty group practices, hospitals, and healthcare systems. Its site footprint spans cities including Raleigh, Atlanta, Charleston, Chattanooga, Dallas, Encino, Lake City, Las Vegas, Mission Viejo, San Diego, Tucson, and Wilmington, organized around dedicated general multi-specialty clinics and mental health specialty clinics covering psychiatry, psychedelic-assisted therapy, and TMS.
The company conducts clinical trials on behalf of biopharmaceutical companies, biotechnology firms, medical device manufacturers, pharmaceutical companies, and CROs across 15 therapeutic areas, including Alzheimer's, autoimmune disorders, cardiology, dermatology, diabetes, gastroenterology, hepatology/nephrology, neurology, obesity, oncology/hematology, orthopedics, pulmonology, women's health, and vaccines/prevention. Its service offering covers the full trial lifecycle: patient recruitment and prescreening, protocol-driven trial execution, data collection and verification, and reporting to sponsors. Underlying capabilities include standardized protocols for cross-site data integrity, end-to-end process management from baseline visits through study completion, and a layered recruitment model combining community physician referrals, email referral programs, a website-based trial finder, and active social media outreach. Reported operating metrics include 476 studies completed and 13,000+ participants enrolled in the last five years.
Wake Research generates revenue through B2B professional services contracts with sponsors and CROs on a per-study basis; specific pricing is not publicly disclosed. The company has expanded primarily through acquisitions, including Medical Center for Clinical Research (2017), Women's Health Care Research in San Diego (November 2021), and Multi-specialty Research Associates in Lake City, Florida (May 2022). Go-to-market combines a dedicated business development team for enterprise sponsor relationships with direct-to-patient enrollment at its owned clinics, supported by a network of community research partners across multiple states.
Wake Research firmographics
Firmographics- Name
- Wake Research
- Legal name
- M3 Wake Research
- Website
- https://wakeresearch.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Wake Research is an integrated U.S. clinical research site network operating 18+ wholly owned investigational clinics across seven states, conducting multi-specialty trials for biopharma, biotech, medical device sponsors, and CROs under parent M3, Inc.
- Ownership category
- akta.pro rank
Wake Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Wake Research is headquartered
LocationHeadquarters
- HQ city
- Raleigh
- HQ country
- United States
- HQ region
- North America
Offices17 records
Markets served
Wake Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Trial Contract Research: Wake Research generates revenue by conducting clinical trials for pharmaceutical companies, biotechnology firms, medical device companies, and CROs. The company operates as an integrated site organization that provides patient recruitment, trial execution, and data collection services in exchange for contractual fees from sponsors.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Wake Research product offering
Product offeringCore offering
Wake Research operates as an integrated site organization of premier investigational sites that conducts clinical trials on behalf of biopharmaceutical, biotechnology, medical device, and pharmaceutical companies as well as CROs. The company provides patient recruitment, trial execution, and data collection services across 15 therapeutic areas through a wholly owned network of 18+ clinical research sites across 7 US states.
Product overview
M3 Wake Research is a clinical research organization operating as a wholly owned, integrated organization of premier investigational sites that span across North America. The company offers a unified platform combining a network of research clinics, participant recruitment services, and multi-specialty clinical trial conduct across 15 therapeutic areas. Their services include end-to-end clinical trial process management from pre-screening through study completion, working with biopharmaceutical companies, biotechnology firms, medical device companies, pharmaceutical companies, and clinical research organizations (CROs) to advance medical treatments and therapies.
Differentiator
Problem solved
Functional benefit
Products and services
- M3 Wake Research Clinical Trial Network An integrated, wholly owned network of premier investigational sites conducting clinical trials for biopharmaceutical, biotechnology, medical device companies, pharmaceutical companies, and CROs across the United States. The network spans 18+ sites across 7 states with 65+ principal investigators.
- Clinical Trial Participant Recruitment Recruitment, qualification, and retention of volunteers for clinical trials, providing diverse and qualified participant populations across multiple therapeutic areas through the site network and community partnerships.
- Multi-Specialty Clinical Research Services Clinical trial conduct across 15 therapeutic areas including Alzheimer's, autoimmune disorders, cardiology, dermatology, diabetes, gastroenterology, hepatology/nephrology, neurology, obesity, oncology/hematology, orthopedics, pulmonology, women's health, and vaccines/prevention.
- Clinical Trial Process Management End-to-end clinical trial management including pre-screening, screening appointments, baseline visits, follow-up visits, and end-of-study coordination with physicians for sponsors and CROs.
- Site Network Operations for Sponsors and CROs Integrated, wholly owned and operated site organization providing exceptional efficiency in delivering top-tier clinical trial patient care with affiliations to multi-specialty group practices, hospitals, and healthcare systems for pharmaceutical sponsors and CROs.
Quantifiable outcome
- 476 studies completed in the last five years
- +3 more outcomes
Companies that use Wake Research
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Wake Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Wake Research partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- Multi-specialty Research Associates (MSRA)coreAcquired Multi-specialty Research Associates in Lake City, Florida, expanding Wake Research's network into the state and enhancing multi-specialty expertise. MSRA brings extensive experience in clinical trials including COVID-19 research.
- Women's Health Care ResearchcoreAcquired Women's Health Care Research in San Diego, expanding Wake Research's network to over 18 sites across seven states. The acquisition included Dr. Rovena Reagan who joined as Medical Director specializing in women's health and clinical research.
- Tucson Endocrinology AssociatesminorCommunity research partner in Tucson, AZ providing patient referrals for endocrinology-related clinical trials.
- Michelson PsychiatryminorCommunity research partner in Mission Viejo, CA specializing in psychiatric clinical trials.
- Santee Community PharmacyminorCommunity research partner in Santee, CA providing patient referrals for clinical trials.
- RDM Magnolia Practice CareminorCommunity research partner in Lake City, FL providing patient referrals for clinical trials.
- Southern Internal MedicineminorCommunity research partner in Lake City, FL providing internal medicine patient referrals.
- Terrell Family PracticeminorCommunity research partner in Lake City, FL providing family practice patient referrals.
- Synergy Medical GroupminorCommunity research partner in Gainesville, FL providing medical group patient referrals.
- Breakthru Psychiatric SolutionsminorCommunity research partner in Sandy Springs, GA specializing in psychiatric clinical trials.
- Nevada Mental HealthminorCommunity research partner in Las Vegas, NV providing mental health patient referrals.
- Premier Physicians Weight Loss and WellnessminorCommunity research partner in Las Vegas, NV providing weight management patient referrals.
- Safe Harbor MedicalminorCommunity research partner in Las Vegas, NV providing medical patient referrals.
- Las Vegas BariatricsminorCommunity research partner in Las Vegas, NV providing bariatric patient referrals.
- Volunteers in Medicine of Southern NevadaminorCommunity research partner in Las Vegas, NV providing volunteer-based medical patient referrals.
- Shaikh Medical ClinicminorCommunity research partner in Garner, NC providing medical patient referrals.
- Summit Endocrinology & DiabetesminorCommunity research partner in Cary, NC providing endocrinology and diabetes patient referrals.
- Wake Family MedicineminorCommunity research partner in Cary, NC providing family medicine patient referrals.
- Tidewater DoctorsminorCommunity research partner in West Ashley, SC providing medical patient referrals.
- Compassionate HealthcareminorCommunity research partner in Hixson, TN providing healthcare patient referrals.
- Diabetes and Endocrinology Clinical Consultants of TexasminorCommunity research partner in Dallas, TX providing diabetes and endocrinology patient referrals.
- A&B NeurologyminorCommunity research partner in Dallas, TX providing neurology patient referrals.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Wake Research competitors and assessment
Company assessmentBroad incumbents
- Medpace: Mid-to-large global CRO with strong site-management and clinical operations capabilities. Comparable to Wake Research as a sponsor-facing clinical research services provider, but operates as a full-service CRO with broader geographic and therapeutic reach.
- IQVIA: Largest global CRO with an integrated site management and patient recruitment offering. Overlaps with Wake Research on the site-network and patient-recruitment functions but operates as a full-service CRO with a much broader portfolio including labs, data, and consulting.
- Syneos Health: Global biopharma solutions organization combining CRO services with a clinical site network (Syneos Site Solutions). Comparable to Wake Research in site operations and patient recruitment, but offers the full clinical-to-commercial value chain.
- ICON plc: Global CRO with site management services and partnerships with investigator site networks. Comparable to Wake Research on clinical trial execution and site services, but operates at far larger scale and with a full-service CRO model.
Direct peers
- DM Clinical Research: US SMO operating multiple clinical research sites with multi-specialty therapeutic coverage. Directly comparable in business model (owned sites, patient recruitment, sponsor contract research) and customer base (biopharma/CRO sponsors).
- Flourish Research: US-based integrated clinical research site network formed through the merger of several independent SMOs. Comparable to Wake Research in operating a multi-site, multi-specialty site network targeting biopharma and CRO sponsors.
- Velocity Clinical Research: One of the largest US-based integrated site management organizations operating premier investigational sites across multiple therapeutic areas. Directly comparable to Wake Research in site-network model, multi-specialty coverage, and direct-to-sponsor GTM motion.
- Centricity Research: US-focused integrated SMO network conducting clinical trials across multiple therapeutic areas. Closely comparable to Wake Research in business model (owned sites, multi-specialty), patient recruitment approach, and sponsor customer base.
- Sundance Clinical Research: Mid-sized US SMO network with multi-specialty clinical trial sites. Comparable to Wake Research as a site-management organization competing for biopharma trials with a similar investigator-led, multi-therapeutic model.
- Alliance for Multispecialty Research (AMR): Multi-specialty SMO network operating investigational sites across the US for pharmaceutical and biotech sponsors. Comparable to Wake Research as a site-based clinical research organization focused on patient recruitment and trial execution across multiple therapeutic areas.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Wake Research social profiles
Digital presenceWake Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wake Research leadership team
Management profileNumber of profiles
Profiles6 records
Wake Research subsidiaries and ownership
Company hierarchySubsidiaries1 record
Wake Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wake Research M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wake Research
What does Wake Research do?
Wake Research operates as an integrated site organization of premier investigational sites that conducts clinical trials on behalf of biopharmaceutical, biotechnology, medical device, and pharmaceutical companies as well as CROs. The company provides patient recruitment, trial execution, and data collection services across 15 therapeutic areas through a wholly owned network of 18+ clinical research sites across 7 US states.
Is Wake Research a public or private company?
Wake Research is a private company. It is classified as corporate owned and is currently operating.
When was Wake Research founded?
Wake Research was founded in 2004. It employs 251 to 500 people.
Where is Wake Research based?
Wake Research is headquartered in Raleigh, United States, in the North America region.
How does Wake Research make money?
One revenue line is on record: clinical Trial Contract Research.
Who are Wake Research's main competitors?
Broad incumbents on record are Medpace, IQVIA, Syneos Health and ICON plc. Direct peers are DM Clinical Research, Flourish Research, Velocity Clinical Research, Centricity Research, Sundance Clinical Research and Alliance for Multispecialty Research (AMR).
Does Wake Research have an API?
No public API is recorded for Wake Research.
What industry is Wake Research in?
Wake Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts). Its NAICS code is 54171 and its SIC code is 8000.